In response to concerns about the impact a US trade deal would have on medicine pricing, the ABPI continues to emphasise that in the UK, we have very strict rules which control medicine spend.
New figures published today by the ABPI show that the pharmaceutical industry continues to invest significantly in UK research and development, working with healthcare professionals and organisations to improve care for NHS patients.
The ABPI has launched new guidance to make sure that joint working between the NHS and industry delivers ‘a triple win’ in benefits for patients, the NHS and companies.
Now that the Party manifestos have now been published, we’ve analysed how their policies will impact the pharmaceutical sector in the UK.
The ABPI has appointed Dr Richard Torbett as its new Chief Executive. He'll take up the job from 1 January.
The ABPI's Chief Executive, Mike Thompson, has announced that he is due to retire at the end of 2019.
Our analysis of the SNP General Election manifesto.
Our analysis of the Labour Party's General Election manifesto, "It's time for real change".
The Conservative Party has launched its General Election manifesto, "Get Brexit Done".
The Conservatives have announced a commitment to further funding for dementia research, doubling existing funding levels.